Related Experiment Video

Updated: Mar 3, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.9K

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status

Aline Gottlieb1, Kristina Althoff1, Laura Grunewald2

  • 1Department of Pediatric Oncology, University Hospital Essen, 45122 Essen, Germany.

Oncotarget
|April 22, 2017
PubMed

Insights

RITA, a novel drug, effectively reduces medulloblastoma cell viability in lab and animal models. This cancer therapy works independently of TP53 status, offering new hope for treating this childhood brain tumor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pediatric Cancer Research

Background:

  • Medulloblastoma, a common childhood brain tumor, has limited survival rates (40-70%) due to chemotherapy resistance.
  • TP53 pathway dysfunction is a key factor in medulloblastoma treatment failure.
  • MDM2 protein targets TP53 for degradation, inhibiting its tumor-suppressive functions.

Purpose of the Study:

  • To investigate the therapeutic potential of RITA, a small-molecule inhibitor, in medulloblastoma.
  • To determine if RITA's efficacy is dependent on the TP53 functional status in medulloblastoma cells.

Main Methods:

  • In vitro studies using four medulloblastoma cell lines to assess RITA's effect on cell viability.
  • Analysis of TP53 protein accumulation and CDKN1A gene expression following RITA treatment.
  • In vivo studies using mouse models with medulloblastoma xenografts to evaluate RITA's anti-tumor activity.

Main Results:

  • RITA significantly decreased medulloblastoma cell viability across all tested cell lines, irrespective of TP53 status.
  • TP53 protein accumulation and increased CDKN1A expression were observed in 3 out of 4 cell lines after RITA treatment.
  • RITA administration effectively inhibited medulloblastoma xenograft tumor growth in vivo.

Conclusions:

  • RITA demonstrates potent anti-cancer activity against medulloblastoma in both in vitro and in vivo models.
  • The therapeutic effect of RITA is independent of the TP53 mutational status.
  • RITA represents a promising therapeutic candidate for medulloblastoma treatment, potentially overcoming TP53-related resistance mechanisms.
Keywords:
CDKN1AMDM2RITATP53medulloblastoma

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K